Dr Justin Bedo
Honorary (Fellow)
Department of Medical Biology (WEHI)
62 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial
DOI: 10.1038/s41416-026-03535-62025
Journal article
Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial
DOI: 10.1038/s41467-025-64130-62025
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.306994012025
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.306994042024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12024
Journal article
BSBM-04 THE MULTI-OMIC LANDSCAPE OF SOMATIC VARIATION ACROSS A PAN-CANCER COHORT OF BRAIN METASTASES
DOI: 10.1093/noajnl/vdae090.0042023
Journal article
Targeting homologous recombination deficiency in uterine leiomyosarcoma
DOI: 10.1186/s13046-023-02687-0
RECENT SCHOLARLY WORKS
2023
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.241351872023
Journal article
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review
DOI: 10.3390/cancers151743782023
Journal article
CIS controls the functional polarization of GM-CSF-derived macrophages
DOI: 10.1038/s41423-022-00957-z